Malignant hyperthermia in young patient undergoing a surgical procedure under general anesthesia

Estéfano Arias Pastrana, Rosa Inés Carrascal Villero, Kevin Santiago Jiménez Escudero and Marlon Munera*

Malignant hyperthermia (MH) is a hypermetabolic disease induced by the administration of anesthetic drugs in patients with genetic susceptibility. Its incidence ranges from 0.02% to 0.0153%. Here, we report the case of an 18-year-old male patient with no previous relevant surgical, medical, or family history of disease, who while undergoing a scheduled orthopedic surgical procedure under general anesthesia for the correction of left congenital talipes equinovarus, presented hyperthermia (41.8°C), muscular stiffness, tachycardia, trismus, increased blood pressure, and increased CO2 levels two hours after the induction of anesthesia. Malignant hyperthermia was suspected and managed following the protocol of the Colombian Anesthesiology and Resuscitation Association (SCARE), and MH diagnosis was confi rmed with response to dantrolene.

Keywords:

Published on: Sep 6, 2019 Pages: 24-26

Full Text PDF Full Text HTML DOI: 10.17352/ojpm.000014
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat